References
- Ozen S, Hoffman HM, Frenkel J, Kastner D. Familial Mediterra-nean fever (FMF) and beyond: a new horizon. Fourth international congress on the systemic autoinflammatory diseases held in Bethesda, USA, 6-10 November 2005. Ann Rheum Dis 2006; 65:961–4.
- Muckle TJ, Wells M. Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med 1962;31:235–48.
- Kubota T, Koike R. Biological and clinical aspects of Muckle-Wells syndrome (in Japanese). Jpn J Clin Immunol 2007;30:114–22.
- INFEVERS Homepage. Available from: http://fmf.igh.cnrs.fr/ ISSAID/infevers/index.php.
- Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003;4:95–104.
- Martinon F,Tschopp J. NLRs join TLRs as innate sensors of patho-gens. Trends Immunol 2005;26:447–54.
- Homepage of Ministry of education, culture, sports, science and technology. Available from: http://www.mext.go.jp/bmenu/houdou/ 18/10/06100304/003/002.pdf.
- Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 2001;29:301–5.
- Hawkins PN, Lachmann HJ. Interleukin-1-receptor antagonist in the Muckle-Wells syndrome. N Engl J Med 2003;348:2583–4.
- Hawkins PN, Lachmann HJ, Aganna E, McDermott ME Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 2004;50:607–12.
- Mirault T, Launay D, Cuisset L, Hachulla E, Lambert M, Queyrel V, et al. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra. Arthritis Rheum 2006;54: 1697–700.
- Rynne M, Maclean C, Bybee A, McDermott MF, Emery P. Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism. Ann Rheum Dis 2006;65: 533–4.
- Feldmann J, Prieur A-M, Quartier P, Berquin P, Certain S, Cortis E, et al. Chronic infantile neurological cutaneous and articular syn-drome is caused by mutations in CIASI, a gene highly expressed in polymorphonucear cells and chondrocytes. Am J Hum Genet 2002;71:198–203.
- Matsubayashi T, Sugiura H, Arai T, Oh-Ishi T, Inamo Y Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIASI gene. Acta Paediatr 2006;95:246–9.
- Matsubara T, Hasegawa M, Shiraishi M, Hoffman HM, Ichiyama T, Tanaka T, et al. A severe case of chronic infantile neurologic, cuta-neous, articular syndrome treated with biologic agents. Arthritis Rheum 2006;54:2314–20.
- Saito M, Fujisawa A, Nishikomori R, Kambe N, Nakata-Hizume M, Yoshimoto M, et al. Somatic mosaicism of CIAS1 in a patient with chronic infantile neurologic, cutaneous, articular syndrome. Arthritis Rheum 2005;52: 3579–85.
- Kagami S, Saeki H, Kuwano Y, Imakado S, Tamaki K. A probable case of Muckle-Wells syndrome. J Dermatol 2006;2:118–21.